Company facts
- Headquarters
- Boston, Massachusetts
- Most recent report
- 10-Q, filed Aug 11, 2026
- Incorporated
- Delaware
- Filings on record
- 370 filings
- On EDGAR
- CIK 1501796
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 21
News 8 of 52
Prospectuses and Registrations 8 of 21
- S-3 Shelf registration statement Aug 11, 2026
- S-8 Registration statement for an employee plan May 19, 2026
- 424B5 Prospectus supplement for an offering May 5, 2026
- 424B5 Prospectus supplement for an offering May 4, 2026
- S-8 Registration statement for an employee plan Mar 30, 2026
- 424B5 Prospectus supplement for an offering May 16, 2025
- 424B5 Prospectus supplement for an offering May 15, 2025
- S-8 Registration statement for an employee plan Mar 24, 2025
Proxies 8 of 15
- DEF 14A Proxy statement for a shareholder vote Jun 29, 2026
- PRE 14A Preliminary proxy statement Jun 17, 2026
- DEFA14A Extra proxy material May 4, 2026
- DEFA14A Extra proxy material Apr 20, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2026
- DEFA14A Extra proxy material Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2025
- DEFA14A Extra proxy material Jun 14, 2024
Ownership 8 of 221
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 3 Insider reported their initial holding Aug 12, 2026
- 3 Insider reported their initial holding Aug 12, 2026
- 3 Insider reported their initial holding Aug 12, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 27, 2026
- 4 Insider reported a trade Jul 8, 2026
Other 8 of 40
- S-3MEF May 4, 2026
- ARS Annual report sent to shareholders Apr 20, 2026
- ARS Annual report sent to shareholders Apr 24, 2025
- ARS Annual report sent to shareholders Apr 25, 2024
- EFFECT Notice that a registration became effective Apr 5, 2024
- CORRESP Reply to SEC staff Apr 3, 2024
- UPLOAD Comment letter from SEC staff Apr 3, 2024
- ARS Annual report sent to shareholders Apr 25, 2023
Everything here comes from Aura Biosciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.